AU2002211281A1 - Quaternary amidino based inhibitors of factor xa - Google Patents

Quaternary amidino based inhibitors of factor xa

Info

Publication number
AU2002211281A1
AU2002211281A1 AU2002211281A AU1128102A AU2002211281A1 AU 2002211281 A1 AU2002211281 A1 AU 2002211281A1 AU 2002211281 A AU2002211281 A AU 2002211281A AU 1128102 A AU1128102 A AU 1128102A AU 2002211281 A1 AU2002211281 A1 AU 2002211281A1
Authority
AU
Australia
Prior art keywords
amidino
quaternary
factor
based inhibitors
inhibitors
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2002211281A
Inventor
Liang Bao
Wenrong Huang
Zhaozhong Jon Jia
Robert M. Scarborough Jr.
Yanhong Wu
Penglie Zhang
Bing-Yan Zhu
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Millennium Pharmaceuticals Inc
Original Assignee
COR Therapeutics Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by COR Therapeutics Inc filed Critical COR Therapeutics Inc
Publication of AU2002211281A1 publication Critical patent/AU2002211281A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/72Nitrogen atoms
    • C07D213/75Amino or imino radicals, acylated by carboxylic or carbonic acids, or by sulfur or nitrogen analogues thereof, e.g. carbamates
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Diabetes (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Hematology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
AU2002211281A 2000-09-29 2001-10-01 Quaternary amidino based inhibitors of factor xa Abandoned AU2002211281A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US23638500P 2000-09-29 2000-09-29
US60/236,385 2000-09-29
PCT/US2001/030314 WO2002026731A2 (en) 2000-09-29 2001-10-01 Quaternary amidino based inhibitors of factor xa

Publications (1)

Publication Number Publication Date
AU2002211281A1 true AU2002211281A1 (en) 2002-04-08

Family

ID=22889271

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2002211281A Abandoned AU2002211281A1 (en) 2000-09-29 2001-10-01 Quaternary amidino based inhibitors of factor xa

Country Status (4)

Country Link
US (1) US20040077690A1 (en)
EP (1) EP1322637A2 (en)
AU (1) AU2002211281A1 (en)
WO (1) WO2002026731A2 (en)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE0102764D0 (en) 2001-08-17 2001-08-17 Astrazeneca Ab Compounds
EP1678161B1 (en) * 2003-10-09 2009-12-30 Millennium Pharmaceuticals, Inc. Thioether-substituted benzamides as inhibitors of factor xa
PT2101760E (en) 2006-12-08 2013-05-07 Millennium Pharm Inc Unit dose formulations and methods of treating thrombosis with an oral factor xa inhibitor
US10059723B2 (en) 2011-02-28 2018-08-28 Biomarin Pharmaceutical Inc. Histone deacetylase inhibitors
US8957066B2 (en) 2011-02-28 2015-02-17 Biomarin Pharmaceutical Inc. Histone deacetylase inhibitors
TW201711566A (en) * 2015-09-28 2017-04-01 拜耳作物科學公司 Method for preparing N-(1,3,4-oxadiazol-2-yl)arylcarboxamides
CN108530349A (en) * 2018-04-09 2018-09-14 重庆三圣实业股份有限公司 The preparation method and products thereof of betrixaban intermediate and betrixaban
CN115057854A (en) * 2022-04-19 2022-09-16 河北常山生化药业股份有限公司 Preparation method of Alvatripopa maleate intermediate

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2002510313A (en) * 1997-06-26 2002-04-02 イーライ・リリー・アンド・カンパニー Antithrombotic substance
RU2226529C2 (en) * 1997-12-19 2004-04-10 Шеринг Акциенгезельшафт Derivatives of ortho-antranilamide as anti-coagulating agents, pharmaceutical composition and method for treatment

Also Published As

Publication number Publication date
US20040077690A1 (en) 2004-04-22
WO2002026731A2 (en) 2002-04-04
WO2002026731A3 (en) 2002-10-03
EP1322637A2 (en) 2003-07-02

Similar Documents

Publication Publication Date Title
AU2001273040A1 (en) Factor xa inhibitors
AU6762400A (en) Inhibitors of factor xa
AU5723500A (en) Inhibitors of factor xa
AU5283700A (en) Inhibitors of factor xa
AU2001249399A1 (en) Isoquinolone inhibitors of factor xa
AU5283900A (en) Inhibitors of factor xa
AU3857300A (en) Inhibitors of factor xa
IL148698A0 (en) INHIBITORS OF FACTOR Xa
AU2002214626A1 (en) Quaternary amines and related inhibitors of factor xa
AU2002351179A1 (en) Glycinamides as factor xa inhibitors
HK1070352A1 (en) Indole-2-carboxamides as factor xa inhibitors
AU2001234689A1 (en) Bivalent phenylene inhibitors of factor xa
AU2001258771A1 (en) -secretase inhibitors
AU2002250394A1 (en) Rho-kinase inhibitors
AU2002245709A1 (en) Rho-kinase inhibitors
AU5284000A (en) Inhibitors of factor xa
AU2002365896A1 (en) SUBSTITUTED AMINO METHYL FACTOR Xa INHIBITORS
AU2001249397A1 (en) Oxindole inhibitors of factor xa
AU2002303264A1 (en) Fused heterocyclic inhibitors of factor xa
AU2001294824A1 (en) Piperazine based inhibitors of factor xa
AU2001297648A1 (en) Substituted carboxamides as inhibitors of factor xa
IL159195A0 (en) Pyrrolidine derivatives as factor xa inhibitors
AU2002367129A1 (en) Organ fibrosis inhibitors
IL162454A0 (en) Pyrrolidine-2-ones as factor xa inhibitors
AU2002211281A1 (en) Quaternary amidino based inhibitors of factor xa